VIWIT PHARM FDA Approval ANDA 213626

ANDA 213626

VIWIT PHARM

FDA Drug Application

Application #213626

Application Sponsors

ANDA 213626VIWIT PHARM

Marketing Status

Prescription001

Application Products

001INJECTABLE;INJECTIONEQ 5MG BASE/ML0PROCHLORPERAZINE EDISYLATEPROCHLORPERAZINE EDISYLATE

FDA Submissions

UNKNOWN; ORIG1AP2021-09-28STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAP

CDER Filings

VIWIT PHARM
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 213626
            [companyName] => VIWIT PHARM
            [docInserts] => ["",""]
            [products] => [{"drugName":"PROCHLORPERAZINE EDISYLATE","activeIngredients":"PROCHLORPERAZINE EDISYLATE","strength":"EQ 5MG BASE\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"09\/28\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2021-09-28
        )

)

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.